SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-012577
Filing Date
2021-03-01
Accepted
2021-03-01 16:42:10
Documents
88
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_wizepharmainc.htm 10-K 1423783
2 DESCRIPTION OF SECURITIES f10k2020ex4-2_wizepharma.htm EX-4.2 20230
3 AMENDMENT TO EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT BY AND BETWEEN WIZE f10k2020ex10-40_wizepharma.htm EX-10.40 26246
4 SUBSIDIARIES OF THE COMPANY f10k2020ex21-1_wizepharma.htm EX-21.1 4221
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2020ex23-1_wizepharma.htm EX-23.1 4298
6 CERTIFICATION f10k2020ex31-1_wizepharma.htm EX-31.1 9794
7 CERTIFICATION f10k2020ex31-2_wizepharma.htm EX-31.2 9145
8 CERTIFICATION f10k2020ex32-1_wizepharma.htm EX-32.1 5631
9 CERTIFICATION f10k2020ex32-2_wizepharma.htm EX-32.2 5880
10 GRAPHIC image_001.jpg GRAPHIC 11822
  Complete submission text file 0001213900-21-012577.txt   6302208

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE wizp-20201231.xml EX-101.INS 996852
12 XBRL SCHEMA FILE wizp-20201231.xsd EX-101.SCH 92758
13 XBRL CALCULATION FILE wizp-20201231_cal.xml EX-101.CAL 56066
14 XBRL DEFINITION FILE wizp-20201231_def.xml EX-101.DEF 232548
15 XBRL LABEL FILE wizp-20201231_lab.xml EX-101.LAB 481368
16 XBRL PRESENTATION FILE wizp-20201231_pre.xml EX-101.PRE 368061
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52545 | Film No.: 21698607
SIC: 2834 Pharmaceutical Preparations